1. 673PDNab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial. (1st October 2019) Authors: Cascinu, S; Berardi, R; Bianco, R; Bilancia, D; Zaniboni, A; Ferrari, D; Mosconi, S; Spallanzani, A; Cavanna, L; Leo, S; Negri, F; Beretta, G D; Sobrero, A; Banzi, M; Morabito, A; Bittoni, A; Marciano, R; Ferrara, D; Noventa, S; Piccirillo, M C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗